AKT1 and type 2 diabetes nephropathy: Previous studies have indicated that Ginsenoside Rh1 ameliorates type 2 diabetic nephropathy by modulating the AMPK/PI3K/AKT signaling pathway, thereby reducing inflammation and cell apoptosis (Su et al. 2021).